Company Profile
Public information reviewed
Indaptus Therapeutics, Inc.
Canonical company identity and public leadership record.
USNASDAQ: INDP
Follow
More
- Public sources
- 1 reviewed
- Published leadership records
- 17
- Last reviewed
- Sep 13, 2026
Agent View
Machine representations
Inspect the same governed public record as Markdown, structured data, or a retrieval endpoint.
Markdown
https://registry.alpha.ac/companies/indaptus-therapeutics-inc.mdIndaptus Therapeutics, Inc.
Alpha governed public record. Unknown, unavailable, and unpublished values are never inferred as zero.
Record
| Field | Value |
|---|---|
| Representation | alpha-profile-markdown-v3 |
| Protocol | Alpha Governance Facts Protocol 0.1 |
| Schema | alpha.governance.entity.public.v1 |
| Record version | public-1 |
| Canonical entity | alpha:company:c90ec6d7-75b6-423f-a873-18a064abae4e |
| Entity type | Company |
| Canonical URL | https://registry.alpha.ac/companies/indaptus-therapeutics-inc |
| Publication | PUBLISHED |
| Verification | source_reported |
| Verification schema | alpha-verification-states-v1 |
| Ownership | unclaimed |
| Published claims | 20 |
| Claims under review | 1 |
| Evidence records | 3 |
| Conflicts | 0 |
| Conflicts in internal review | 0 |
| Observed | 2026-09-13T04:46:26.757159+00:00 |
| Last reviewed | 2026-09-13T04:46:26.757159+00:00 |
Identity
- Legal name: Indaptus Therapeutics, Inc.
- Display name: Indaptus Therapeutics, Inc.
Leadership
- Anthony J. Maddaluna: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:2.
- Avraham Ben-Tzvi: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:2.
- David E. Lazar: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:2.
- David Natan: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:2.
- Jeffrey A. Meckler: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:2.
- Jerome D. Jabbour: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:2.
- Mark J. Gilbert: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:2.
- Matthew McMurdo: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:2.
- Michael J. Newman: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:2.
- Roger J. Pomerantz: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:2.
- William B. Hayes: Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:2.
- David E. Lazar: Co-Chief Executive Officer and Chairman. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:3.
- Jeffrey A. Meckler: Co-Chief Executive Officer and Director. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:3.
- Matthew McMurdo: Vice President, New Strategies. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:3.
- Michael J. Newman, Ph.D.: Chief Scientific Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:3.
- Nir Sassi: Chief Financial Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:3.
- Walt A. Linscott, Esq.: Chief Operating Officer. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:3.
Roles
- PUBLISHED
Governance
- NOT_ASSERTED
Board committees
- PUBLISHED
Financials
- NOT_ASSERTED
Workforce
- NOT_ASSERTED
Market and index context
- PUBLISHED
Legal Name
- Indaptus Therapeutics, Inc.. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:1.
Headquarters
- US. Publication: UNDER_REVIEW. Verification: source_reported. Assertion: source_reported. Evidence: unlinked, under review.
Entity Status
- Public listing published. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:1.
Published Fact
- US. Publication: PUBLISHED. Verification: source_reported. Assertion: source_reported. Evidence: alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:1.
Coverage states
| Field | Value |
|---|---|
| Identity | PUBLISHED |
| Business | PUBLISHED |
| Leadership | PUBLISHED |
| Board and committees | PUBLISHED |
| Governance | NOT_ASSERTED |
| Financials | NOT_ASSERTED |
| Workforce | NOT_ASSERTED |
| Ownership | NOT_ASSERTED |
| Ratings | NOT_PUBLISHED |
| Market and index context | PUBLISHED |
Public sources
- alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:1: Alpha canonical company public projection.
- alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:2: Indaptus Therapeutics, Inc. DEF 14A 2026-01-21.
- alpha:evidence:company:c90ec6d7-75b6-423f-a873-18a064abae4e:3: INDP 10-K executive officers.
Rights
| Field | Value |
|---|---|
| public_retrieval | allowed |
| agent_retrieval | allowed |
| redistribution | not_granted |
| model_training | not_granted |
| commercial_use | not_specified |
| relationship_pathfinding | not_granted |
| direct_contact | not_granted |
Limitations
- Absence of a leadership role, committee, or disclosure is not evidence that it does not exist.
- Only explicitly published canonical company identity and current confirmed public roles are included.
- Absence of a board, committee, executive, listing, or claim is not evidence that it does not exist.
- Public retrieval does not grant redistribution, model-training, direct-contact, or relationship-pathfinding rights.
- This Company Profile is an identity and evidence record, not an Alpha rating.
Alternate representations
- Canonical profile
- Public Markdown
- Public JSON
- JSON-LD
- MCP resource:
alpha://companies/indaptus-therapeutics-incat https://mcp.alpha.ac/mcp